Hepatitis C is a virus that affects the liver which can often go untreated due to lack of symptoms, often causing severe damage. According to World Health Organisation, as many as 60% of all cases of liver cancer can be attributed to viral hepatitis infections, with an estimated 71 million people affected by chronic hepatitis C infection worldwide*.
With such prevalence a great number of diagnostic tests are required to ensure the accurate identification, tracking and treatment of the disease.
We are pleased to be able to offer a range of high quality components to Hepatitis C and related proteins to manufacturers and researchers worldwide.
Among these are monoclonal antibodies and recombinant antigens, suitable for use in many assay types including ELISA.
Take a look at our specific products via the links below. or click HERE to browse the range.
*Source: WHO Hepatitis C factsheet